Figure 7From: Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study Probability* of pneumonia by 156 weeks by baseline post-bronchodilator FEV 1 % predicted. *Kaplan-Meier probability.Back to article page